Advocating for Impact: The Price is Right? – The Administration’s Drug Pricing Plans
This podcast will provide members with analysis of the Administration’s actions on drug pricing to date, including proposed tariffs and two separate Executive Orders (EOs). We’ll talk through key elements of the EO on Most Favored Nation pricing, how it might intersect with the earlier, more general EO on drug pricing, and what these policy shifts could mean for members. We’ll also discuss how potential tariffs on pharmaceuticals might further complicate the drug pricing picture.
The information presented during the podcast reflects solely the opinions of the presenter. The information and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.